FFCP PHASE1:Mm9::chr18:60659912..60659934,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:60659912..60659934,+|id=chr18:60659912..60659934,+|ontology_enrichment_celltype=CL:0000988!2.75e-13!32;CL:0002032!2.75e-13!32;CL:0000037!2.75e-13!32;CL:0000566!2.75e-13!32;CL:0000837!2.75e-13!32;CL:0000049!1.06e-10!19;CL:0000219!1.19e-09!54;CL:0002320!1.43e-08!46;CL:0000134!1.43e-08!46;CL:0000034!2.93e-08!97;CL:0000144!1.07e-07!121;CL:0000012!1.07e-07!121;CL:0000325!4.11e-07!2;CL:0000217!4.11e-07!2;CL:0000328!4.11e-07!2;CL:0002573!4.11e-07!2;CL:0002376!4.11e-07!2;CL:0000218!4.11e-07!2;CL:0000692!4.11e-07!2;CL:0002377!4.11e-07!2;CL:0002375!4.11e-07!2|ontology_enrichment_celltype_v019_2=CL:0000049,1.10e-10,19;CL:0000557,7.11e-08,7;CL:0000034,3.44e-07,97|ontology_enrichment_disease=DOID:0060100!7.63e-12!3;DOID:4045!7.63e-12!3|ontology_enrichment_disease_v019_2=DOID:0060100,1.03e-18,3;DOID:4045,1.03e-18,3;DOID:0050686,1.21e-09,6|ontology_enrichment_uberon=UBERON:0002384!1.43e-08!46|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0,0,0,0,0,0,0,0,0,0.157731082679119,0.137114433605739,0,0,0.198581902401771,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.8818223991596,4.6880120671428,5.23523743973798,49.9996764826362,20.4913645487534,7.2826552954673,0,0,0,0,0,0,0,0,0,0.335565212115473,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.11519323715393,5.39912457894067,6.60765180779936,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150704817835715,0,0,0,0,0,0,0,0,0,0,0,0,2.1066395619397,4.37491442095016,2.84163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.54967644990783,3.77868921273877,3.17859939750175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0941093804153306,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr18:60659912..60659934,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:60659912..60659934,+ | |||
|description=CAGE_peak_at_chr18:60659912..60659934,+ | |||
|id=chr18:60659912..60659934,+ | |||
|ontology_enrichment_celltype=CL:0000988!2.75e-13!32;CL:0002032!2.75e-13!32;CL:0000037!2.75e-13!32;CL:0000566!2.75e-13!32;CL:0000837!2.75e-13!32;CL:0000049!1.06e-10!19;CL:0000219!1.19e-09!54;CL:0002320!1.43e-08!46;CL:0000134!1.43e-08!46;CL:0000034!2.93e-08!97;CL:0000144!1.07e-07!121;CL:0000012!1.07e-07!121;CL:0000325!4.11e-07!2;CL:0000217!4.11e-07!2;CL:0000328!4.11e-07!2;CL:0002573!4.11e-07!2;CL:0002376!4.11e-07!2;CL:0000218!4.11e-07!2;CL:0000692!4.11e-07!2;CL:0002377!4.11e-07!2;CL:0002375!4.11e-07!2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000049,1.10e-10,19;CL:0000557,7.11e-08,7;CL:0000034,3.44e-07,97 | |||
|ontology_enrichment_disease=DOID:0060100!7.63e-12!3;DOID:4045!7.63e-12!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.03e-18,3;DOID:4045,1.03e-18,3;DOID:0050686,1.21e-09,6 | |||
|ontology_enrichment_uberon=UBERON:0002384!1.43e-08!46 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0,0,0,0,0,0,0,0,0,0.157731082679119,0.137114433605739,0,0,0.198581902401771,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.8818223991596,4.6880120671428,5.23523743973798,49.9996764826362,20.4913645487534,7.2826552954673,0,0,0,0,0,0,0,0,0,0.335565212115473,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.11519323715393,5.39912457894067,6.60765180779936,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150704817835715,0,0,0,0,0,0,0,0,0,0,0,0,2.1066395619397,4.37491442095016,2.84163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.54967644990783,3.77868921273877,3.17859939750175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0941093804153306,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr18:60659912..60659934,+ | |||
}} |
Latest revision as of 22:36, 5 August 2015
Short description: | p@chr18:60659912..60659934, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:60659912..60659934, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
common myeloid progenitor | 1.10e-10 | 19 |
granulocyte monocyte progenitor cell | 7.11e-08 | 7 |
stem cell | 3.44e-07 | 97 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.03e-18 | 3 |
muscle cancer | 1.03e-18 | 3 |
organ system cancer | 1.21e-09 | 6 |